Analysts are smiling on Q&M Dental and keeping a positive outlook on the stock following its strong 1QFY2021 ended March and its robust Covid-19 testing business.

On May 18, Q&M announced that its 51%-owned subsidiary Acumen was awarded a tender by the Health Promotion Board (HPB) for the provision of Covid-19 swab and testing services. It will be a panel service provider of the HPB in respect of the Covid-19 swab and testing services.

Following this news, shares in surged some 3.6% when the market opened to 72 cents.


To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook